Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.
Cardiology July 22nd 2024
MedCentral
The inclusion of Medicare Advantage data and increased emphasis on patient outcomes in the US News Best Hospitals rankings further illustrates the growing importance of comprehensive, coordinated care in today’s healthcare landscape.
All Specialties July 22nd 2024
Annals of Internal Medicine
This target trial emulation study provides critical insights into weight change associated with eight first-line antidepressants, emphasizing the minimal weight gain with bupropion. Clinicians should integrate these findings into treatment decisions to address patient concerns about weight gain.
Endocrinology, Diabetes, Metabolism July 10th 2024
The New England Journal of Medicine
In a Chinese study, tenecteplase administered 4.5 to 24 hours after stroke onset resulted in less disability at 90 days compared to standard treatment, though it carried a higher risk of symptomatic intracranial hemorrhage.
Neurology July 3rd 2024
Oncology News Central (ONC)
Many modern oncology trials prioritize drug approval over patient welfare, often using inferior control arms that do not reflect the best available treatment.
Oncology, Medical July 2nd 2024
Pain Medicine News
Integrating telehealth into opioid treatment programs drastically improves hepatitis C cure rates, particularly among underserved populations, by facilitating seamless access to DAAs and continuous follow-up care.
Hepatology June 24th 2024